Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 173

1.

Frontolimbic atrophy is associated with agitation and aggression in mild cognitive impairment and Alzheimer's disease.

Trzepacz PT, Yu P, Bhamidipati PK, Willis B, Forrester T, Tabas L, Schwarz AJ, Saykin AJ; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2013 Oct;9(5 Suppl):S95-S104.e1. doi: 10.1016/j.jalz.2012.10.005. Epub 2012 Dec 17.

2.

Agitation in Alzheimer's disease is a manifestation of frontal lobe dysfunction.

Senanarong V, Cummings JL, Fairbanks L, Mega M, Masterman DM, O'Connor SM, Strickland TL.

Dement Geriatr Cogn Disord. 2004;17(1-2):14-20. Epub 2003 Oct 13.

PMID:
14560060
3.

Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease.

Jack CR Jr, Wiste HJ, Vemuri P, Weigand SD, Senjem ML, Zeng G, Bernstein MA, Gunter JL, Pankratz VS, Aisen PS, Weiner MW, Petersen RC, Shaw LM, Trojanowski JQ, Knopman DS; Alzheimer's Disease Neuroimaging Initiative.

Brain. 2010 Nov;133(11):3336-48. doi: 10.1093/brain/awq277. Epub 2010 Oct 8.

4.

Anatomical correlates of the neuropsychiatric symptoms in Alzheimer's disease.

Hu X, Meiberth D, Newport B, Jessen F.

Curr Alzheimer Res. 2015;12(3):266-77.

PMID:
25731626
5.

Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease.

Portelius E, Zetterberg H, Skillbäck T, Törnqvist U, Andreasson U, Trojanowski JQ, Weiner MW, Shaw LM, Mattsson N, Blennow K; Alzheimer’s Disease Neuroimaging Initiative.

Brain. 2015 Nov;138(Pt 11):3373-85. doi: 10.1093/brain/awv267. Epub 2015 Sep 15.

6.

Posterior Atrophy and Medial Temporal Atrophy Scores Are Associated with Different Symptoms in Patients with Alzheimer's Disease and Mild Cognitive Impairment.

Hsu JL, Lee WJ, Liao YC, Lirng JF, Wang SJ, Fuh JL.

PLoS One. 2015 Sep 15;10(9):e0137121. doi: 10.1371/journal.pone.0137121. eCollection 2015.

7.

Subscale validation of the neuropsychiatric inventory questionnaire: comparison of Alzheimer's disease neuroimaging initiative and national Alzheimer's coordinating center cohorts.

Trzepacz PT, Saykin A, Yu P, Bhamditipati P, Sun J, Dennehy EB, Willis B, Cummings JL; Alzheimer's Disease Neuroimaging Initiative.

Am J Geriatr Psychiatry. 2013 Jul;21(7):607-22. doi: 10.1016/j.jagp.2012.10.027. Epub 2013 Apr 18.

8.

Utility of combinations of biomarkers, cognitive markers, and risk factors to predict conversion from mild cognitive impairment to Alzheimer disease in patients in the Alzheimer's disease neuroimaging initiative.

Gomar JJ, Bobes-Bascaran MT, Conejero-Goldberg C, Davies P, Goldberg TE; Alzheimer's Disease Neuroimaging Initiative.

Arch Gen Psychiatry. 2011 Sep;68(9):961-9. doi: 10.1001/archgenpsychiatry.2011.96.

PMID:
21893661
9.

Early diagnosis of Alzheimer's disease using cortical thickness: impact of cognitive reserve.

Querbes O, Aubry F, Pariente J, Lotterie JA, Démonet JF, Duret V, Puel M, Berry I, Fort JC, Celsis P; Alzheimer's Disease Neuroimaging Initiative.

Brain. 2009 Aug;132(Pt 8):2036-47. doi: 10.1093/brain/awp105. Epub 2009 May 12.

10.

Neuroanatomical correlates of neuropsychiatric symptoms in Alzheimer's disease.

Bruen PD, McGeown WJ, Shanks MF, Venneri A.

Brain. 2008 Sep;131(Pt 9):2455-63. doi: 10.1093/brain/awn151. Epub 2008 Jul 11.

PMID:
18669506
11.

An MRI brain atrophy and lesion index to assess the progression of structural changes in Alzheimer's disease, mild cognitive impairment, and normal aging: a follow-up study.

Zhang N, Song X, Zhang Y, Chen W, D'Arcy RC, Darvesh S, Fisk JD, Rockwood K; Alzheimer's disease Neuroimaging Initiative.

J Alzheimers Dis. 2011;26 Suppl 3:359-67. doi: 10.3233/JAD-2011-0048.

PMID:
21971475
12.

Depressive symptoms in mild cognitive impairment predict greater atrophy in Alzheimer's disease-related regions.

Lee GJ, Lu PH, Hua X, Lee S, Wu S, Nguyen K, Teng E, Leow AD, Jack CR Jr, Toga AW, Weiner MW, Bartzokis G, Thompson PM; Alzheimer's Disease Neuroimaging Initiative.

Biol Psychiatry. 2012 May 1;71(9):814-21. doi: 10.1016/j.biopsych.2011.12.024. Epub 2012 Feb 8.

13.

Neuropsychiatric symptoms and regional neocortical atrophy in mild cognitive impairment and Alzheimer's disease.

Rafii MS, Taylor CS, Kim HT, Desikan RS, Fleisher AS, Katibian D, Brewer JB, Dale AM, Aisen PS.

Am J Alzheimers Dis Other Demen. 2014 Mar;29(2):159-65. doi: 10.1177/1533317513507373. Epub 2013 Oct 27.

14.

Mibampator (LY451395) randomized clinical trial for agitation/aggression in Alzheimer's disease.

Trzepacz PT, Cummings J, Konechnik T, Forrester TD, Chang C, Dennehy EB, Willis BA, Shuler C, Tabas LB, Lyketsos C.

Int Psychogeriatr. 2013 May;25(5):707-19. doi: 10.1017/S1041610212002141. Epub 2012 Dec 21.

15.

Alzheimer's disease pattern of brain atrophy predicts cognitive decline in Parkinson's disease.

Weintraub D, Dietz N, Duda JE, Wolk DA, Doshi J, Xie SX, Davatzikos C, Clark CM, Siderowf A.

Brain. 2012 Jan;135(Pt 1):170-80. doi: 10.1093/brain/awr277. Epub 2011 Nov 21.

16.

Cognitive reserve and Alzheimer's disease biomarkers are independent determinants of cognition.

Vemuri P, Weigand SD, Przybelski SA, Knopman DS, Smith GE, Trojanowski JQ, Shaw LM, Decarli CS, Carmichael O, Bernstein MA, Aisen PS, Weiner M, Petersen RC, Jack CR Jr; Alzheimer's Disease Neuroimaging Initiative.

Brain. 2011 May;134(Pt 5):1479-92. doi: 10.1093/brain/awr049. Epub 2011 Apr 7.

17.

Longitudinal progression of Alzheimer's-like patterns of atrophy in normal older adults: the SPARE-AD index.

Davatzikos C, Xu F, An Y, Fan Y, Resnick SM.

Brain. 2009 Aug;132(Pt 8):2026-35. doi: 10.1093/brain/awp091. Epub 2009 May 4.

18.

Agitation-associated behavioral symptoms in mild cognitive impairment and Alzheimer's dementia.

Van der Mussele S, Le Bastard N, Saerens J, Somers N, Mariën P, Goeman J, De Deyn PP, Engelborghs S.

Aging Ment Health. 2015;19(3):247-57. doi: 10.1080/13607863.2014.924900. Epub 2014 Jun 25.

PMID:
24962058
19.

Cognitive and structural magnetic resonance imaging features of Lewy body dementia and Alzheimer's disease.

Rodriguez MJ, Potter E, Shen Q, Barker W, Greig-Custo M, Agron J, Loewenstein D, Duara R.

Alzheimers Dement. 2012 May;8(3):211-8. doi: 10.1016/j.jalz.2011.04.008.

PMID:
22546353
20.

Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease.

Jack CR Jr, Lowe VJ, Weigand SD, Wiste HJ, Senjem ML, Knopman DS, Shiung MM, Gunter JL, Boeve BF, Kemp BJ, Weiner M, Petersen RC; Alzheimer's Disease Neuroimaging Initiative.

Brain. 2009 May;132(Pt 5):1355-65. doi: 10.1093/brain/awp062. Epub 2009 Mar 31.

Supplemental Content

Support Center